The role of the tumor microenvironment in HIV-associated lymphomas

Biomark Med. 2015;9(5):473-82. doi: 10.2217/bmm.15.13.

Abstract

There has been considerable interest in the role of the lymphoma microenvironment. Despite the use of highly active antiretroviral therapy (HAART), AIDS-related diffuse large-B-cell lymphoma remains common and HIV-relatedHIV-associated classical Hodgkin's lymphoma is increasing in incidence. Less is known about the impact HIV and HAART have on the lymphoma microenvironment. AIDS-related diffuse large B-cell lymphoma is highly angiogenic, demonstrates increased lymphoblastic histology, proliferation, increased activated cytotoxic T cells, reduced CD4(+) and FOXP3(+) T cells, but no differences in tumor-associated macrophages. Early initiation of HAART improves immunosurveillance, but cases without viral antigens appear able to avoid immunologic reaction. Increased T cell infiltrates seen with HAART treatment in HIV-related classical Hodgkin's lymphoma may contribute to malignant cell growth.

Keywords: HIV-related diffuse large B-cell lymphoma; Hodgkin's lymphoma; Tat; angiogenesis; immunosurveillance; impact of highly active antiretroviral therapy; p17; tumor microenvironment.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Hodgkin Disease / pathology
  • Humans
  • Lymphoma, AIDS-Related / pathology*
  • Tumor Microenvironment / physiology*